N/A N=87 The Efficiency of the Hair2Go Device: A Prospective, Open, Label Study With Before-After Design
Hair Removal
Primary: Hair Clearance 1 Month After Last Treatment — 56.83; 54.08 %baseline hair count
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=10 Ultrasound Device for Hair Removal
Hair Removal
Primary: Reduction in Hair Count in the Treated Area — 13.1; 10.7; 18.7 percentage of hair reduction
Phase 3 N=20 Comparison of Efficacy, Safety and Tolerability of Two Different 810 nm Diode Lasers for Hair Reduction
Hypertrichosis
Primary: Change in Hair Growth — 57.6; 52.1; 39.3; 29.9 % hair reduction — p=0.2879
N/A N=11 Pilot Study of a Novel IPL for Removal of Unwanted Fine Body Hair
Hypertrichosis
Primary: Comparison of Percent Hair Reduction Between Treatment Arm and Non-treated Control Arm at 12 Weeks Post Final Treatment — 41; 27 percent reduction
N/A N=37 Safety for Frequent Use Conditions of Hair Removal Device
Hair Removal
Primary: Percentage of Participants With Device Related Anticipated Skin Effects, Serious Adverse Events, or Adverse Events. — 0; 0; 0 percentage of particpants
N/A N=35 Hair Count Reduction Verification Study With the LightSheer Duet HS Handpiece
Hair Removal
Primary: Hair Count — 54 percentage of hair clearance — p=<0.001
N/A N=17 Clinical Evaluation of Silk'n Glide for Face
Hirsutism
Primary: 1. Comparison of Hair Counts Before Treatments to 4 and 12 Weeks Follow up Visits. — 83.3; 78.1 percentage of hair reduction
N/A N=13 Pilot Study of Laser Hair Depilation for Pilonidal Disease
Pilonidal Disease
Primary: Tolerability of Laser Treatment — 2 score on a scale
N/A N=63 Hair2Go Label Comprehension and Usability Study
Hair Removal
Primary: Percent of Participants Correctly Determining Eligibility for Use of the Device (Responders) — 94 percentage of participants
N/A N=44 A Novel Approach to Treating Androgenetic Alopecia in Females With Low Level Laser Therapy
Androgenetic Alopecia
Primary: Percentage Increase in Terminal Hair Counts From Pre-Treatment, Baseline for Active Test Subjects Over the Placebo Test Subjects. — 12.48; 63.67 percent change — p=<0.001
Phase 2 N=20 Trial of Topical Cidofovir for the Prevention of Hair Growth
Prevention of Hair Growth
Primary: Physician's Global Assessment (PGA) of Hair Density — 1; 0; 1 participants
N/A N=29 Pre-Shave Gel and Brush in Pseudofolliculitis Barbae
Pseudofolliculitis Barbae
Primary: Patient Global Severity Assessment- Mechanics of Shaving — 12.9; 12.4; 8.5; 9.7 score on a scale
N/A N=23 Treatment of Keratosis Pilaris With 810 nm Diode Laser
Keratosis Pilaris (KP)
Primary: Difference in Disease Severity Scores — 4; 3 units on a scale
N/A N=17 Evaluation of 1440nm Laser vs. Botulinum Toxin or miraDry® Microwave For Treatment of Axillary Hyperhidrosis
Hyperhidrosis
Primary: Change in Sweating Assessed Using Gravimetry — 267.91; 57.36; 155.14 mg
Phase 1 N=3 Topical Imiquimod in Conjunction With Nd:YAG Laser for Tattoo Removal
Healthy
Primary: Efficacy of Tattoo Removal Using Topical Imiquimod 5% Cream — 4.3; 2.7 percentage of tattoo pigment removed
N/A N=5 Evaluation of 1440nm Laser Assisted Selective Photothermolysis for Treatment of Axillary Hyperhidrosis
Hyperhidrosis
Primary: Change in Sweating Assessed Using Gravimetry — -104.50; -90.85 mg
N/A N=72 Treatment of Androgenetic Alopecia in Females, 9 Beam
Androgenetic Alopecia · Hair Loss · Female Pattern Baldness
Primary: Changes in Terminal Hair Count Week 16 and 26 Weeks Over Baseline — 1.3; 14.8; 2.8; 20.2 hairs per cm^2
N/A N=11 Radiofrequency and Pulsed Electromagnetic Field Treatment of Skin Laxity of the Mon Pubis, Labia and Vaginal Introitus
Skin Laxity
Primary: General Skin Appearance of Mons Pubis and Labia — 3; 4; 1 Participants
N/A N=39 Clinical Evaluation of a 1060 nm Diode Laser, PEMF and Vacuum Assisted MP RF for Non-invasive Fat Reduction
Adipose Tissue Atrophy
Primary: Change in Aesthetic Appearance From Baseline — 0.97 score on a scale
N/A N=27 Multi-Wavelength Laser Tattoo Removal Pivotal Study
Tattoo Removal
Primary: Tattoo Clearing as Rated by Blinded Evaluator — 21 Participants
N/A N=20 Laser Removal of Age (Sun) Spots on Hands
Solar Lentigines
Primary: Median VAS Improvement Score as Assessed by Blinded Physician Reviewers — 1.5 units on a scale — p=<0.0001
N/A N=63 Treatment of Androgenetic Alopecia in Females, 12 Beam
Androgenetic Alopecia · Hair Loss · Female Pattern Baldness
Primary: Change in Hair Count at 16 and 26 Weeks Over Baseline — -0.8; 12.5; 3.0; 20.6 hairs per cm^2
N/A N=25 Silk'n HST Device Usability and Self Selection Study
Wrinkles
Primary: Usability Assessment — 25 Participants
N/A N=42 Study of Picosecond and Nanosecond Q-switched Lasers for Tattoo Removal
Tattoo Removal
Primary: Tattoo Clearing at 6 Weeks Post-final Laser Treatment for Each Treatment Arm as Assessed by Blinded Reviewers. — 2.54; 2.17 score on a scale
N/A N=36 Computer-Assisted Versus Manual Hair Harvest Comparative Study
Androgenetic Alopecia
Primary: Increase in Hair Follicles Present — 16.9; 18.3 Hair follicles — p=0.023
N/A N=33 Evaluation of the 755nm Alexandrite Laser for the Treatment of Scars
Scars
Primary: Photographic Evaluation of Scar Clearance — 1.82 score on a scale
N/A N=60 Subcutaneous Fat Reduction in the Submental Area
Body Fat Disorder
Primary: Safety of CoolScupting in the Submental Area — 4 incidence of device- and/or procedure AE
N/A N=15 CoolSculpting Treatment in the Upper Arms
Body Fat Disorder
Primary: Proportion of Correctly Identified Pre-treatment Photos — 26 photos
N/A N=20 Evaluation of the 755nm Alexandrite Laser for the Treatment of Tattoos
Tattoos
Primary: Tattoo Clearance Using Photographic Evaluation — 15; 6; 2 Tattoos
N/A N=11 Treatment of Acne Keloidalis Nuchae (Razor Bumps Behind the Neck) Using UV Light Therapy
Acne Keloidalis Nuchae
Primary: Percentage Change in Total AKN Lesions From Baseline to Week 16. — 49 percentage of lesion count reduction